Concentration of leukotriene C4 (LT C4) in subretinal fluid and plasma of 12 patients with idiopathic retinal detachment has been studied. In 10 cases the subretinal fluid contained LT C4 (0.34 +/- 0.24 ng/ml) and concentration of this substance was about 10 times lower than that observed in plasma (4.05 +/- 0.83 ng/ml). The presence of LT C4 in subretinal fluid may result from retinal damage and it can be considered as an important prognostic factor.
Download full-text PDF |
Source |
---|
Ophthalmol Retina
March 2025
Moorfields Eye Hospital, London, United Kingdom; UCL Institute of Ophthalmology, University College London, London, United Kingdom. Electronic address:
Purpose: To analyze the retinal imaging findings and natural history of Best vitelliform macular dystrophy (BVMD).
Design: Single-center retrospective, consecutive, observational study.
Participants: Patients with a clinical diagnosis of BVMD, from pedigrees with a likely disease-causing monoallelic variant in BEST1.
J Fr Ophtalmol
March 2025
Department of Ophthalmology, University of Health Sciences, Basaksehir Cam and Sakura City Hospital, Basaksehir Olympic Boulevard Road, Basaksehir, Istanbul, Turkey.
Purpose: To evaluate the efficacy of navigated subthreshold micropulse laser (NSML) compared to subthreshold micropulse laser (SML) without navigation in the management of chronic central serous chorioretinopathy (CSCR).
Materials And Methods: This retrospective study included patients diagnosed with chronic CSCR who underwent either NSML or SML without navigation. Patients meeting inclusion criteria presented with serous macular detachment and leakage at the level of the retinal pigment epithelium on fundus fluorescein angiography (FFA).
Int Ophthalmol
March 2025
Department of Ophthalmology, Cathay General Hospital, 280, Sec. 4, Ren-Ai Road, Taipei, Taiwan.
Purpose: To investigate the risk factors for visual outcomes and recurrence of macular edema (ME) in branch retinal vein occlusion (BRVO) after intravitreal injection (IVI) of anti-vascular endothelial growth factor (anti-VEGF) agents.
Methods: Thirty eyes of 30 patients with recent-onset, treatment naive BRVO with ME receiving IVI aflibercept and ranibizumab in a tertiary care hospital were enrolled retrospectively. Treatment response was classified into "responsive group" and "recurrent/refractory group" by absence or presence of ME after consecutive monthly IVI anti-VEGF therapy.
Ophthalmic Surg Lasers Imaging Retina
March 2025
Background And Objective: While anti-vascular endothelial growth factor (anti-VEGF) therapy has revolutionized treatment for diabetic macular edema, many patients still manifest refractory disease. This study evaluated rates of diabetic macular edema (DME) refractory to intravitreal bevacizumab in a diverse real-world setting, with the aim of studying demographic and optical coherence tomography (OCT)-based morphological factors associated with refractory disease.
Patients And Methods: This was a retrospective cohort study of patients receiving treatment.
Front Immunol
March 2025
Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Purpose: To report an uncommon case of Vogt-Koyanagi-Harada (VKH) disease in an elderly patient with unilateral choroidal detachment and describe its multimodal imaging features and prognosis.
Method: Case report and literature review of clinical features in VKH with choroidal detachment.
Results: A 76-year-old woman presented with bilateral blurred vision and headache 6 months prior to visiting our hospital.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!